These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21147673)

  • 1. [Aspergillus peritonitis--a case report].
    Patyi M; Svébis M
    Magy Seb; 2010 Dec; 63(6):384-6. PubMed ID: 21147673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial cerebral aspergillosis: a report of 3 cases.
    Darras-Joly C; Veber B; Bedos JP; Gachot B; Regnier B; Wolff M
    Scand J Infect Dis; 1996; 28(3):317-9. PubMed ID: 8863371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalized Patient as Source of Aspergillus fumigatus, 2015.
    Lemaire B; Normand AC; Forel JM; Cassir N; Piarroux R; Ranque S
    Emerg Infect Dis; 2018 Aug; 24(8):1524-1527. PubMed ID: 30014836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aspergillus tracheobronchitis in a lung transplant recipient].
    García-Gallo CL; García-Fadul C; Laporta-Hernández R; Ussetti-Gil P
    Rev Iberoam Micol; 2011; 28(3):129-33. PubMed ID: 21700233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients.
    Harari S
    Drugs; 1999 Oct; 58(4):621-31. PubMed ID: 10551434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus oryzae peritonitis in CAPD: case report and review of the literature.
    Schwetz I; Horina J; Buzina W; Roob J; Olschewski H; Krause R
    Am J Kidney Dis; 2007 May; 49(5):701-4. PubMed ID: 17472853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
    Lahmer T; Messer M; Ehmer U; Eser S; Beitz A; Fekecs L; Schmid RM; Huber W
    Mycopathologia; 2016 Apr; 181(3-4):267-71. PubMed ID: 26455910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].
    Pozo-Laderas JC; Pontes-Moreno A; Robles-Arista JC; Bautista-Rodriguez MD; Candau-Alvarez A; Caro-Cuenca MT; Linares-Sicilia MJ
    Rev Iberoam Micol; 2015; 32(1):46-50. PubMed ID: 23583263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
    Cordonnier C; Bresnik M; Ebrahimi R
    Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for a eumycetoma infection caused by Aspergillus in an immunocompromised host: a case report.
    Hopps S; Roach A; Yuen C; Borders E
    Transpl Infect Dis; 2015 Feb; 17(1):94-7. PubMed ID: 25537527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated invasive aspergillosis in a patient with acute leukaemia.
    Gottfredsson M; Steingrímsdóttir H
    Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden loss of vision in an Acute Medical Unit.
    Arif M; Jordaan J; Garcia Arias V
    Acute Med; 2014; 13(1):26-8. PubMed ID: 24616901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A painful knee in an immunocompromised patient.
    Pattison RM; O'Donnell MA; Powles R; Moss AL
    Postgrad Med J; 1997 Jan; 73(855):49-50. PubMed ID: 9039414
    [No Abstract]   [Full Text] [Related]  

  • 14. Invasive pulmonary aspergillosis with intraspinal extension in a non-immunocompromised host. A case report.
    Cherian SM; Keshavamurthy S; Madhu Sankar N; Kurian VM; Sivaraman A; Verghese S; Cherian KM
    J Cardiovasc Surg (Torino); 2002 Apr; 43(2):291-3. PubMed ID: 11887073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of anaerobic micro-organisms in intra-abdominal infections].
    Menozzi MG; Chezzi C
    Ann Ist Super Sanita; 1987; 23(4):899-905. PubMed ID: 3330649
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment and developmental therapeutics in aspergillosis. 1. Amphotericin B and its derivatives.
    Georgiev VS
    Respiration; 1992; 59(5):291-302. PubMed ID: 1488564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pulmonary aspergillosis and pulmonary cryptococcosis really coexist in immunocompromised host.
    Lin CM; Tsai YH; Huang CC; Lee CH; Chiang PC; Huang SF; Liu HP
    J Infect; 2006 Aug; 53(2):e55-8. PubMed ID: 16325257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
    Oren I; Haddad N; Finkelstein R; Rowe JM
    Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
    Viscoli C; Castagnola E
    Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AmBisome treatment of pulmonary aspergillosis in a patient with tuberculosis.
    Viggiani P; Besozzi G
    Acta Biomed; 2006; 77 Suppl 4():31-3. PubMed ID: 17370569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.